Macrogenics reported $-24813000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US USD 3.95B 3.03B
Amgen AMGN:US USD 1.62B 527M
AstraZeneca AZN:LN USD 1.64B 1.28B
Biogen BIIB:US USD 1.13B 76.7M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Daiichi Sankyo 4568:JP JPY 28.39B 11.07B
Eli Lilly And LLY:US USD 1.94B 486M
Genmab GEN:DC DKK 2.58B 691M
Gilead Sciences GILD:US USD 1.64B 149M
Immunogen IMGN:US USD -77755000 15.73M
Johnson & Johnson JNJ:US USD 3.52B 938M
Karyopharm Therapeutics KPTI:US USD -36324000 12.74M
Macrogenics MGNX:US USD -24813000 16.49M
Merk MRK:US USD 3.02B 231M
Mirati Therapeutics MRTX:US USD -173561000 2.88M
Pfizer PFE:US USD 5B 3.61B
Regeneron Pharmaceuticals REGN:US USD 1.2B 118.6M
Roche Holding ROG:VX 8.53B 2.4B
Seattle Genetics SGEN:US USD -190816000 55.99M
Xencor XNCR:US USD -32759000 1.22M